NOS2 Gene Hypertension Susceptibility Test in UAE | 2800 AED | DHA-Accredited NGS Analysis

Executive Summary & Core Metrics

99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited NGS Workflow (Cert: INT/EGQ/2509DA/3139).
Premium Home Collection – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance – Telephonic post-test counselling by DHA-licensed genetic specialists.
Direct Billing – WhatsApp insurance verification: +971 54 548 8731.

Test Overview & Methodology

The NOS2 Gene Hypertension Susceptibility Test is a Next-Generation Sequencing (NGS)-based genetic assay that identifies inherited variants in the NOS2 gene associated with an elevated risk of essential hypertension and related vascular disorders. Designed for proactive health management, this test empowers UAE patients and clinicians to tailor prevention strategies under DHA-approved protocols. Full-gene coverage ensures detection of both common and rare variants that influence nitric oxide synthesis, vascular inflammation, and antihypertensive drug response.

Feature	Our NOS2 NGS Test	Standard PCR Genotyping
Precision	>99.9% analytical sensitivity & specificity (full-gene coverage)	85-92% – limited to known hotspots only
Methodology	Next Generation Sequencing (Illumina®-based, LOINC 81247-8)	Allele-specific PCR / Sanger sequencing fragments
Turnaround Time	3-4 weeks (comprehensive report)	4-6 weeks (often requires reflex testing)
Clinical Utility	Actionable variants for hypertension, vascular inflammation & drug response	Limited to a few polymorphisms; low predictive value

Physician Insight & Safety Protocols

"A positive NOS2 variant indicates a predisposition, not a diagnosis. Clinical correlation with family history, serial blood pressure monitoring, and lifestyle assessment remains essential. My team reviews every result to ensure the genetic data is translated into a safe, individualized care pathway." – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)

Advisory: Medication Safety Precautions

⚠️ Important Clinical Warning

Do not discontinue or adjust any prescribed antihypertensive, anti-inflammatory, or other medication based solely on genetic test results. Always consult your treating physician before making any changes to your medication regimen.

Exclusion Criteria & Emergency Red Flags

Exclusion: Individuals unable to provide informed consent; active uncontrolled hypertensive crisis (systolic >180 mmHg or diastolic >120 mmHg) at the time of sample collection; children below 1 year of age.
Immediate ER referral if: Sudden severe headache, chest pain, vision loss, or new-onset neurological deficit after testing – these are hypertensive emergencies unrelated to the genetic test itself but require urgent evaluation.

Patient FAQ & Clinical Guidance

1. What does a positive NOS2 genetic variant mean?

A positive result indicates an inherited predisposition to hypertension, not a definitive diagnosis, and requires clinical correlation. Your cardiologist or genetic counsellor will interpret the variant within the context of your personal and family health history to design a surveillance plan that may include periodic blood pressure monitoring and lifestyle modifications.

2. Is the test painful and how is the sample collected?

A simple blood draw or a single drop of blood on an FTA card is virtually painless and takes only minutes. Our DHA-licensed phlebotomist performs the collection at your home using a sterile, single-use kit; you receive results within 3-4 weeks. The sample is transported under temperature-controlled cold-chain logistics to preserve genomic integrity.

3. How does this test comply with UAE privacy laws?

Your genomic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, with strict encryption and no third-party sharing. The ISO-certified facility maintains physical and digital safeguards; you control any release of information through informed consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.

UAE Regulatory & Data Privacy Adherence

This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted in transit and at rest, access is restricted to authorized clinical personnel only, and no information is shared with third parties without explicit patient consent. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and follows DHA standards for genetic testing and reporting.

Clinical & Logistical Metadata

Test Name	NOS2 Gene Hypertension Susceptibility Test
Price (AED)	2,800 AED
Turnaround Time	3-4 weeks
Sample Type / Matrix	Peripheral whole blood or saliva (FTA card accepted)
Methodology Used	Next Generation Sequencing (NGS) – Illumina® platform, full-gene coverage
ICD-10-CM Code	Z15.89, I10, Z13.6
LOINC Code	81247-8
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab: DNA Labs UAE